2015
DOI: 10.1134/s0006297915120068
|View full text |Cite
|
Sign up to set email alerts
|

Age-related changes in ultrastructure of mitochondria. Effect of SkQ1

Abstract: For many years, investigators have attempted to identify unique ultrastructural conditions of mitochondria related to aging. However, this did not result in definitive results. At present, this issue has again become of topical interest due to development of the mitochondrial theory of aging and of engineering of a novel antioxidant class known as mitochondria-targeted antioxidants. The review briefly discusses experimental results that, from our perspective, allow the most objective understanding regarding ag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Nowadays, SkQ1 is being used in many fields: inflammation [122,123], wound healing [122,124], tumor growth suppression [125], Alzheimer's disease [126], fertility [127], aging [128,129], immunoregulation [130], ischemia [131] and mitochondrial diseases [132,133] among others. All of them are related with mitochondrial function and ROS homeostasis.…”
Section: Plastoquinone and Skq1mentioning
confidence: 99%
See 1 more Smart Citation
“…Nowadays, SkQ1 is being used in many fields: inflammation [122,123], wound healing [122,124], tumor growth suppression [125], Alzheimer's disease [126], fertility [127], aging [128,129], immunoregulation [130], ischemia [131] and mitochondrial diseases [132,133] among others. All of them are related with mitochondrial function and ROS homeostasis.…”
Section: Plastoquinone and Skq1mentioning
confidence: 99%
“…Idebenone LHON Approved for patients' treatment [46][47][48] Friedreich ataxia Patients' treatment [27,[49][50][51] Pulmonary fibrosis Tested in vivo [64] Dementia Patients' treatment [65] MELAS Patients' treatment [66] Glaucoma Patients' treatment [67] Mitoquinone Heart failure Tested in vivo [76] Hypertension Tested in vivo [77] Diabetic kidney disease Tested in vivo [78] Alcoholic fatty liver disease Tested in vivo [79] Hepatitis C Patients' treatment [80] Parkinson's disease Patients' treatment [81,82] Alzheimer's disease Tested in vivo [83,84] Huntington's disease Tested in vivo [85] Amyotrophic lateral sclerosis Tested in vivo [86] Traumatic brain injury Tested in vivo [87] Decylubiquinone LHON In vitro studies [102] Cancer Tested in vivo [103][104][105] Hypertension Tested in vivo [106] SkQ1 Inflammation Tested in vivo [122,123] Wound healing Tested in vivo [122,124] Tumor growth suppression In vitro studies [125] Alzheimer's disease Tested in vivo [126] Fertility Tested in vivo [127] Aging Tested in vivo [128,129] Immunoregulation Tested in vivo [130] Ischemia Tested in vivo [131] Dry eye treatment Patients' treatment…”
Section: Coenzyme Q 10 Analogue Medical Applications Level Of Study Rmentioning
confidence: 99%